Combined ω3 and ω6 supplementation in children with attention-deficit hyperactivity disorder (ADHD) refractory to methylphenidate treatment: a double-blind, placebo-controlled study.

Hemamali, Perera,; Kamal Chandima, Jeewandara,; Sudarshi, Seneviratne,; Chandima, Guruge,

doi:10.1177/0883073811435243

Public

Combined ω3 and ω6 supplementation in children with attention-deficit hyperactivity disorder (ADHD) refractory to methylphenidate treatment: a double-blind, placebo-controlled study.

Published in Journal of child neurology • Jun 1, 2012

Authors:

Perera, Hemamali

Jeewandara, Kamal Chandima

Seneviratne, Sudarshi

Abstract

Children (6-12 years) with attention-deficit hyperactivity disorder (ADHD) being treated with methylphenidate and standard behavior therapy for more than 6 months, whose parents reported no improvement in behavior and academic learning, were randomly assigned to receive supplementation with a combin...

Subject

Attention Deficit Disorder with Hyperactivity

Behavior Therapy

Central Nervous System Stimulants

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!